These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3170213)

  • 1. Comments on 'Alternatives to the BEIR relative risk model for explaining atomic bomb survivor cancer mortality'.
    Nambi KS; Soman SD
    Health Phys; 1988 Sep; 55(3):579-80. PubMed ID: 3170213
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternatives to the BEIR relative risk model for explaining atomic-bomb survivor cancer mortality.
    Cohen BL
    Health Phys; 1987 Jan; 52(1):55-63. PubMed ID: 3804743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study.
    Howe GR; McLaughlin J
    Radiat Res; 1996 Jun; 145(6):694-707. PubMed ID: 8643829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary factors and cancer mortality among atomic-bomb survivors.
    Sauvaget C; Kasagi F; Waldren CA
    Mutat Res; 2004 Jul; 551(1-2):145-52. PubMed ID: 15225589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996).
    Little MP
    Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957
    [No Abstract]   [Full Text] [Related]  

  • 11. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
    Little MP; Hoel DG; Molitor J; Boice JD; Wakeford R; Muirhead CR
    Radiat Res; 2008 Jun; 169(6):660-76. PubMed ID: 18494541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cancer mortality among atomic bomb survivors in Hiroshima Prefecture, 1968-1997.
    Zhunussova T; Matsuura M; Hayakawa N
    Hiroshima J Med Sci; 2003 Mar; 52(1):1-7. PubMed ID: 12701647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of radiation and smoking on lung cancer risk among Atomic bomb survivors.
    Pierce DA; Sharp GB; Mabuchi K
    Radiat Res; 2005 Jun; 163(6):694-5. PubMed ID: 16044494
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival analyses of atomic bomb survivors in Hiroshima Prefecture, Japan, 1968-1982--cancer mortality risk among early entrants.
    Matsuura M; Hayakawa N; Shimokata H
    Hiroshima J Med Sci; 1995 Jun; 44(2):29-38. PubMed ID: 7591838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint analysis of site-specific cancer risks for the atomic bomb survivors.
    Pierce DA; Preston DL
    Radiat Res; 1993 May; 134(2):134-42. PubMed ID: 8488248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of leukemia in Japanese atomic bomb survivors, in women treated for cervical cancer, and in patients treated for ankylosing spondylitis.
    Little MP; Weiss HA; Boice JD; Darby SC; Day NE; Muirhead CR
    Radiat Res; 1999 Sep; 152(3):280-92. PubMed ID: 10453089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the mortality of A-bomb survivors. 7. Mortality, 1950-1978: Part I. Cancer mortality.
    Kato H; Schull WJ
    Radiat Res; 1982 May; 90(2):395-432. PubMed ID: 7079470
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation-induced cancer and its modifying factor among A-bomb survivors.
    Kato H
    Princess Takamatsu Symp; 1987; 18():117-24. PubMed ID: 3506538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.